Taken together, these data, including our own results, suggest that the inactivation of p16INK4A/p14ARF locus in these carcinomas is rare and that in contrast, the upregulation of these genes could be associated with thyroid cancer progression. The gene discussed is CDKN2A; the disease is thyroid gland carcinoma.